Please use this identifier to cite or link to this item:
https://www.um.edu.mt/library/oar/handle/123456789/44342| Title: | The pharmacokinetics of the antiviral agents indicated in influenza : what are the clinical implications? |
| Authors: | Mifsud, Janet |
| Keywords: | Antiviral agents -- Pharmacodynamics Influenza -- Chemotherapy Antiviral agents -- Development Amantadine |
| Issue Date: | 2006-03 |
| Publisher: | Medical Portals Ltd. |
| Citation: | Mifsud, J. (2006). The pharmacokinetics of the antiviral agents indicated in influenza : what are the clinical implications? The Synapse : the Medical Professionals' Network, 2, 8-9. |
| Abstract: | Several of the recent advances in antiviral drug development indicated in influenza have been due to the improved pharmacokinetic properties of the drugs now available. There are four licensed influenza antiviral agents which are now available. Amantadine, rimantadine, and oseltamivir are administered orally, while zanamir is given as a dry powder that is self-administered visa oral inhalation. |
| URI: | https://www.um.edu.mt/library/oar/handle/123456789/44342 |
| Appears in Collections: | The Synapse, Issue 02/06 The Synapse, Issue 02/06 |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| The_Synapse,_2-06_-_A5.pdf | 1.46 MB | Adobe PDF | View/Open |
Items in OAR@UM are protected by copyright, with all rights reserved, unless otherwise indicated.